Previous | Next
Skeletal Plasmacytoma Progression of disease and impact of local treatment
Skeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER database
Muhammad UMAR Jawad and Sean P Scully
Journal of Hematology & Oncology 2009, 2:41 Full text available
Previous reports suggest an as yet unidentifiable subset of patients with plasmacytoma will progress to myeloma. The current study sought to establish the risk of developing myeloma and determine the prognostic factors affecting the progression of disease.
Plasmacytoma consists of two cohorts of patients with different overall survival; those patients that do not progress to systemic disease and those that develop myeloma. Age> 60 years is associated with disease progression. Identifying patients with systemic disease early in the treatment will permit aggressive and novel treatment strategies to be implemented.
Type: Reference Material
Author/Contact: Muhammad UMAR Jawad and Sean P Scully
Institution: Journal of Hematology & Oncology
Submitted by: admin
Added: Sun Sep 27 2009